TP53MT was common in MDS and AML patients in agreement with other studies26,27, while our earlier analyses have shown that a second TP53 lesion was the most common hit associated with TP53MT14 and that second TP53 hits are likely sweeping lesions12. The gene discussed is TP53; the disease is acute myeloid leukemia.